SFX by Ex Libris Inc.

Title:	Mutant SOD1 causes motor neuron disease independent of copper chaperone–mediated copper loading
Source:	Nature Neuroscience [1097-6256] Subramaniam, Jamuna yr:2002

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wong, P C C. "An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria." Neuron 14.6 (1995): 1105-16.
description	2.	Klivenyi, P. "Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis." Nature medicine 5.3 (1999): 347-50.
description	3.	Williamson, L. "Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons." Nature neuroscience 2.1 (1999): 50-56.
description	4.	Carroll, M. "Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone." Proceedings of the National Academy of Sciences of the United States of America 101.16 (2004): 5964-5969.
description	5.	UCHIDA, K. "IDENTIFICATION OF OXIDIZED HISTIDINE GENERATED AT THE ACTIVE-SITE OF CU,ZN-SUPEROXIDE DISMUTASE EXPOSED TO H2O2 - SELECTIVE GENERATION OF 2-OXO-HISTIDINE AT THE HISTIDINE-118." The Journal of biological chemistry 269.4 (1994): 2405-2410.
description	6.	Bruijn, D W I. "Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1." Science 281.5384 (1998): 1851-1854.
description	7.	Deng, H X X. "Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation." Science 264.5166 (1994): 1772-5.
description	8.	Shefner, J M M. "A clinical trial of creatine in ALS." Neurology 63.9 (2004): 1656-61.
description	9.	Marklund, N. "Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat." Experimental neurology 197.1 (2005): 70-83.
description	10.	Rothstein, L I I. "ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions." Neuron 18.2 (1997): 327-38.
description	11.	Ligon, Lee A A. "Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons." Neuroreport 16.6: 533-536.
description	12.	"Accelerated S-Nitrosothiol Breakdown by Amyotrophic Lateral Sclerosis Mutant Copper,Zinc-Superoxide Dismutase." Journal of biological chemistry. 276.43: 39872-39878.
description	13.	Partridge, F.A. A. "The C. elegans glycosyltransferase BUS-8 has two distinct and essential roles in epidermal morphogenesis." Developmental biology 317.2: 549-59.
description	14.	Behrens, C. "Development of Strategies for the Site-Specific In Vivo Incorporation of Photoreactive Amino Acids: p-Azidophenylalanine, p-Acetylphenylalanine and Benzofuranylalanine." Tetrahedron 56.48 (2000): 9443-9449.
description	15.	Lamb, AL. "Heterodimeric structure of superoxide dismutase in complex with its metallochaperone." Nature structural biology 8.9 (2001): 751-755.
description	16.	Liu, Jian W. "Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria." Neuron 43.1 (2004): 5-17.
description	17.	Clement, A M M. "Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice." Science 302.5642: 113-117.
description	18.	Peña-Altamira, E. "Neurochemical correlates of differential neuroprotection by long-term dietary creatine supplementation." Brain research 1058.1/2: 183-188.
description	19.	Hall, E D D. "Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS." GLIA 23.3 (1998): 249-56.
description	20.	Liebetanz, D. "Extensive exercise is not harmful in amyotrophic lateral sclerosis." The European journal of neuroscience 20.11: 3115-20.